(S (S (NP (DT The) (NN polypharmacy) (NN side) (NN effect) (NN prediction) (NN problem)) (VP (NNS considers) (NP (NP (NNS cases)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (CD two) (NNS drugs)) (VP (VBN taken) (ADVP (RB individually)))) (VP (VBP do) (RB not) (VP (VB result) (PP (IN in) (NP (DT a) (JJ particular) (NN side) (NN effect)))))))))) (: ;) (S (ADVP (RB however)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (CD two) (NNS drugs)) (VP (VBP are) (VP (VBN taken) (PP (IN in) (NP (NN combination))))))) (, ,) (NP (DT the) (NN side) (NN effect)) (VP (NNS manifests))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (JJ multi-relational) (NN knowledge) (NN graph) (NN completion)) (VP (VBZ achieves) (NP (NP (JJ state-of-the-art) (NNS results)) (PP (IN on) (NP (DT the) (NN polypharmacy) (NN side) (NN effect) (NN prediction) (NN problem)))))))) (. .))
(S (NP (JJ Empirical) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (NN approach)) (VP (VBZ is) (ADJP (RB particularly) (JJ effective)) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN protein) (NNS targets)) (PP (IN of) (NP (DT the) (NNS drugs)))) (VP (VBP are) (ADJP (JJ well-characterized))))))))) (. .))
(S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (JJ prior) (NN work))))) (, ,) (NP (PRP$ our) (NN approach)) (VP (VBZ provides) (NP (NP (ADJP (RBR more) (JJ interpretable)) (NNS predictions) (CC and) (NNS hypotheses)) (PP (IN for) (NP (NN wet) (NN lab) (NN validation))))) (. .))
